In murine models of psoriasis, injection of botulinum toxins (both A and B) reduces accumulation of CD4 and CD11 cells and IL17 within the psoriatic lesion [25,26], as well as decreasing the level of cytokines (Table 2). This evidence concerns the gene IL17A and psoriasis.